Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media

Thiol-terminated polyethylene glycol (PEG) is commonly used to functionalize the surface of gold nanoparticles (AuNPs) in order to improve their in vivo stability and to avoid uptake by the reticular endothelial system. Although it has been reported that AuNPs functionalized with tethered PEG are stable in biological media, the influence of chain density remains unclear. This study investigates the influence of PEG capping density on the stability of washed and dried AuNPs in: water, phosphate-buffered saline solution (PBS), phosphate-buffered saline solution containing bovine serum albumin (PBS/BSA), and dichloromethane (DCM). PEG coating had a dramatic effect on stability enabling stable suspensions to be produced in all the media studied. A linear relationship was observed between capping density and stability in water and DCM with a somewhat lower stability observed in PBS and PBS/BSA. A maximum PEG loading level of ∼14 wt.% was achieved, equivalent to a PEG surface density of ∼1.13 chains/nm2.

[1]  Kazunori Kataoka,et al.  Ligand density effect on biorecognition by PEGylated gold nanoparticles: regulated interaction of RCA120 lectin with lactose installed to the distal end of tethered PEG strands on gold surface. , 2005, Biomacromolecules.

[2]  M. Natan,et al.  Seeding of Colloidal Au Nanoparticle Solutions. 2. Improved Control of Particle Size and Shape , 2000 .

[3]  L. Sperling.  Introduction to physical polymer science , 1986 .

[4]  Sihai Chen,et al.  Synthesis and Characterization of Carboxylate-Modified Gold Nanoparticle Powders Dispersible in Water , 1999 .

[5]  C. Rao,et al.  Nanomaterials – An Introduction , 2005 .

[6]  Q. Pankhurst,et al.  Before striking gold in gold-ruby glass , 2000, Nature.

[7]  A. S. Dunn.  Introduction to physical polymer science (2nd edition). By L. H. Sperling, New York, 1992 John Wiley & Sons Inc. John Wiley & Sons Inc., New York, 1992. pp. xxvii + 594, price £55.00. ISBN 0‐471‐53035‐2 , 1994 .

[8]  M. S. Muthu,et al.  Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. , 2009, Nanomedicine.

[9]  G. Frens.  Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions , 1973 .

[10]  Lucienne Juillerat-Jeanneret,et al.  The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles? , 2008, Drug discovery today.

[11]  Victoria M Hitchins,et al.  Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators , 2011, Nanotoxicology.

[12]  Hamidreza Ghandehari,et al.  Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[14]  Takayuki Takahagi,et al.  Optical spectroscopic studies of the dispersibility of gold nanoparticle solutions , 2002 .

[15]  R. Narain,et al.  Monodisperse Protein Stabilized Gold Nanoparticles via a Simple Photochemical Process , 2008 .

[16]  A. Haes,et al.  Linear assembly of gold nanoparticle clusters via centrifugation. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[17]  Vincent M Rotello,et al.  Gold nanoparticles in delivery applications. , 2008, Advanced drug delivery reviews.

[18]  Giulio F. Paciotti,et al.  Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors , 2006 .

[19]  Younan Xia,et al.  Shape‐Controlled Synthesis of Gold and Silver Nanoparticles. , 2003 .

[20]  S. Yuk,et al.  Gold/chitosan/pluronic composite nanoparticles for drug delivery , 2008 .

[21]  Sangjin Park,et al.  Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007 .

[22]  J. Hillier,et al.  A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .

[23]  Naomi J Halas,et al.  Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH. , 2009, Nano letters.

[24]  Ming Zheng,et al.  Ethylene glycol monolayer protected nanoparticles for eliminating nonspecific binding with biological molecules. , 2003, Journal of the American Chemical Society.

[25]  Sang-Kee Eah,et al.  Charged gold nanoparticles in non-polar solvents: 10-min synthesis and 2D self-assembly. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[26]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[27]  C. Ah,et al.  Size-Controlled Synthesis of Machinable Single Crystalline Gold Nanoplates , 2005 .

[28]  Lawrence Tamarkin,et al.  Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery , 2004, Drug delivery.

[29]  A. Anne,et al.  Terminal attachment of polyethylene glycol (PEG) chains to a gold electrode surface. cyclic voltammetry applied to the quantitative characterization of the flexibility of the attached PEG chains and of their penetration by mobile PEG chains , 2002 .

[30]  Jean-Marie Devoisselle,et al.  Magnetic nanoparticles and their applications in medicine. , 2006, Nanomedicine.

[31]  R. G. Freeman,et al.  Preparation and Characterization of Au Colloid Monolayers , 1995 .

[32]  W. Chan,et al.  Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50-200 nm. , 2009, Journal of the American Chemical Society.

[33]  J. Kimling,et al.  Turkevich method for gold nanoparticle synthesis revisited. , 2006, The journal of physical chemistry. B.

[34]  C. Murphy,et al.  Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution. , 2004, Journal of the American Chemical Society.

[35]  Paul Henman.  Targeted! , 2004 .

[36]  K. Hamad-Schifferli,et al.  Selective release of multiple DNA oligonucleotides from gold nanorods. , 2009, ACS nano.

[37]  C. Mirkin,et al.  Controlling anisotropic nanoparticle growth through plasmon excitation , 2003, Nature.

[38]  V. Rotello,et al.  Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. , 2006, Journal of the American Chemical Society.

[39]  Kazunori Kataoka,et al.  Quantitative and Reversible Lectin-Induced Association of Gold Nanoparticles Modified with α-Lactosyl-ω-mercapto-poly(ethylene glycol) , 2001 .

[40]  J. B. Hall,et al.  Characterization of nanoparticles for therapeutics. , 2007, Nanomedicine.

[41]  Mathias Brust,et al.  Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .

[42]  M. Vossoughi,et al.  In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells , 2010, Biotechnology Letters.

[43]  Heather Sheardown,et al.  Polyethylene oxide surfaces of variable chain density by chemisorption of PEO-thiol on gold: adsorption of proteins from plasma studied by radiolabelling and immunoblotting. , 2005, Biomaterials.

[44]  G. Higby,et al.  Gold in medicine , 1982, Gold bulletin.